Rebecca Leigh King MD

PubMed

• International consensus statement on diagnosis, evaluation, and research of Richter transformation: the ERIC recommendations.
  Adam S Kittai, Monia Marchetti, Othman Al-Sawaf, Ohad Benjamini, Alexey V Danilov
  Blood. 2025-07-17
• Integrated genomics with refined cell-of-origin subtyping distinguishes subtype-specific mechanisms of treatment resistance and relapse in diffuse large B-cell lymphoma.
  Janek S Walker, Kerstin Wenzl, Joseph P Novak, Matthew E Stokes, Melissa A Hopper
  Blood Cancer Journal. 2025-07-12
• Low grade B-cell Neurolymphomatosis: A Case Series and Diagnostic Insight.
  Ken Porche, Rebecca L King, Thomas Habermann, Patrick B Johnston, Robert J Spinner
  World Neurosurgery. 2025-07-08

Abstracts/Posters

• Clinical Features and Treatment for Neurolymphomatosis in the Rituximab Era: Single Institution Experience
  Rebecca L. King, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Event-Free Survival at 24 Months Following Autologous Stem Cell Transplant in Diffuse Large B-Cell Lymphoma
  Rebecca L. King, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Response to Erythropoiesis Stimulating Agents in Patients with WHO-Defined Myelodysplastic Syndrome/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytos...
  Rebecca L. King, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Immunoglobulin Variable Gene Region (IGVL) Usage Correlates with Distinct Clinical Presentation in IgM Versus Non-IgM Light Chain Amyloidosis
  Rebecca L. King, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Clustering of Transcriptomic Signatures in Newly Diagnosed Diffuse Large B-Cell Lymphoma Identifies Two High-Risk Subgroups Which Increase in Prevalence at Relapse
  Rebecca L. King, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Genomic Analysis of R2CHOP-Treated DLBCL Reveals a High-Risk Population Driven By Inflammatory Pathways
  Rebecca L. King, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Genomic Landscape Including Novel Mutational Drivers in Relapsed/Refractory Diffuse Large B Cell Lymphoma
  Rebecca L. King, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Waldenstr_m Macroglobulinemia with Excess Plasma Cells: Is It a Distinct Entity?
  Rebecca L. King, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Potential Factors That Impact Lenalidomide/R-CHOP Efficacy in Previously Untreated Diffuse Large B-Cell Lymphoma in the ROBUST and ECOG-ACRIN 1412 Studies
  Rebecca L. King, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all